Loading...

Avantor, Inc.

AVTRNYSE
Basic Materials
Chemicals - Specialty
$13.07
$-0.47(-3.43%)

Avantor, Inc. (AVTR) Stock Overview

Explore Avantor, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Revenue Growth
-2.64%
2.64%
Profit Growth
$1.05
121.58%
EPS Growth
$1.05
118.75%
Operating Margin
16.39%
55.77%
ROE
12.42%
121.58%
Dividend Yield
0.00%

Analyst Recommendations

Strong Buy
0
Buy
5
Hold
4
Sell
0
Strong Sell
0

Price Targets

Low$15.00
Average$24.40
High$28.00

Company Profile

Avantor, Inc. provides products and services to customers in biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, clinical, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Avantor, Inc. was founded in 1904 and is headquartered in Radnor, Pennsylvania.

CEO

Mr. Michael Stubblefield

Employees

13,500

Headquarters

Radnor Corporate Center, Radnor, PA

Founded

2019

Frequently Asked Questions